Follow the Clinical Laserthermia Systems AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Clinical Laserthermia Systems AB has published 1 public disclosures. Market capitalisation: €61.7m. The latest transaction was disclosed on 17 July 2025 (Purchase). Among the most active insiders: Jimmy Johansson. All data is openly available.
Analysts rate Clinical Laserthermia Systems AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 7.60.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Clinical Laserthermia Systems AB is a Swedish company specializing in the development of laser treatment technologies for the healthcare sector. It focuses on innovative solutions for the treatment of cancer and other diseases.